Zynex, Inc. Stockholder Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against ZYXI
Portfolio Pulse from
Robbins LLP has filed a class action lawsuit against Zynex, Inc. (ZYXI) alleging the company inflated revenues by shipping excess products and filing false insurance claims. On March 11, 2025, Zynex reported a significant revenue shortfall and revealed Tricare temporarily suspended payments, causing the stock to drop 51.3% to $3.41 per share.
March 24, 2025 | 10:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Zynex faces potential legal and financial consequences from alleged improper revenue reporting and insurance claim practices, with Tricare suspending payments
The class action lawsuit and Tricare payment suspension directly impact Zynex's financial credibility, likely leading to continued stock price pressure and potential regulatory penalties
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100